Robert Thomas Freeman
Chief Financial Officer · Alignment Healthcare, Inc.
- 2024
- Nov 13, 2024
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Thomas Freeman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Dawn Christine Maroney - $9.99M in ALHC purchases and sales in the last 12 months
- Joseph S. Konowiecki - $3.46M in ALHC purchases and sales in the last 12 months
- Hyong Kim - $1.31M in ALHC purchases and sales in the last 12 months
- Andreas P. Wagner - $1.27M in ALHC purchases and sales in the last 12 months
- Christopher J. Joyce - $769K in ALHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Thomas Freeman?
Robert Thomas Freeman is a corporate insider, tracked as Chief Financial Officer of Alignment Healthcare, Inc. (ALHC). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Robert Thomas Freeman last file a Form 4?
The most recent primary Form 4 on record is dated 13 November 2024, one of 5 filings going back to 2024.
Has Robert Thomas Freeman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.05M) across all tracked filings.
